カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の医薬品用プロバイオティクス市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Pharmaceutical Ggrade Probiotics Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19535）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19535
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：113
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の医薬品用プロバイオティクス市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

医薬品用プロバイオティクス市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の医薬品用プロバイオティクスの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

医薬品用プロバイオティクス市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・ビフィズス菌、乳酸菌、その他

用途別セグメントは次のように区分されます。
・機能性食品、栄養補助食品、その他

世界の医薬品用プロバイオティクス市場の主要な市場プレーヤーは以下のとおりです。
・DuPont (Danisco)、Chr. Hansen、Lallemand、China-Biotics、Nestle、Danone、Probi、BioGaia、Yakult、Novozymes、Valio、Glory Biotech、Greentech、Bioriginal、Biosearch Life

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、医薬品用プロバイオティクス製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な医薬品用プロバイオティクスメーカーの企業概要、2019年～2022年までの医薬品用プロバイオティクスの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な医薬品用プロバイオティクスメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別医薬品用プロバイオティクスの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの医薬品用プロバイオティクスの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での医薬品用プロバイオティクス市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および医薬品用プロバイオティクスの産業チェーンを掲載しています。
・第13、14、15章では、医薬品用プロバイオティクスの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 医薬品用プロバイオティクスの概要
- 種類別分析（2017年vs2021年vs2028年）：ビフィズス菌、乳酸菌、その他
- 用途別分析（2017年vs2021年vs2028年）：機能性食品、栄養補助食品、その他
- 世界の医薬品用プロバイオティクス市場規模・予測
- 世界の医薬品用プロバイオティクス生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- DuPont (Danisco)、Chr. Hansen、Lallemand、China-Biotics、Nestle、Danone、Probi、BioGaia、Yakult、Novozymes、Valio、Glory Biotech、Greentech、Bioriginal、Biosearch Life
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：ビフィズス菌、乳酸菌、その他
・用途別分析2017年-2028年：機能性食品、栄養補助食品、その他
・医薬品用プロバイオティクスの北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・医薬品用プロバイオティクスのヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・医薬品用プロバイオティクスのアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・医薬品用プロバイオティクスの南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・医薬品用プロバイオティクスの中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Pharmaceutical Ggrade Probiotics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Pharmaceutical Ggrade Probiotics market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Nutraceuticals accounting for % of the Pharmaceutical Ggrade Probiotics global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Bifidobacterium segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Pharmaceutical Ggrade Probiotics include DuPont (Danisco), Chr. Hansen, Lallemand, China-Biotics, and Nestle, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Pharmaceutical Ggrade Probiotics market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Bifidobacterium
Lactobacillus
Others
Market segment by Application can be divided into
Nutraceuticals
Dietary Supplements
Others
The key market players for global Pharmaceutical Ggrade Probiotics market are listed below:
DuPont (Danisco)
Chr. Hansen
Lallemand
China-Biotics
Nestle
Danone
Probi
BioGaia
Yakult
Novozymes
Valio
Glory Biotech
Greentech
Bioriginal
Biosearch Life
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pharmaceutical Ggrade Probiotics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Pharmaceutical Ggrade Probiotics, with price, sales, revenue and global market share of Pharmaceutical Ggrade Probiotics from 2019 to 2022.
Chapter 3, the Pharmaceutical Ggrade Probiotics competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pharmaceutical Ggrade Probiotics breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Pharmaceutical Ggrade Probiotics market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Pharmaceutical Ggrade Probiotics.
Chapter 13, 14, and 15, to describe Pharmaceutical Ggrade Probiotics sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Pharmaceutical Ggrade Probiotics Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Pharmaceutical Ggrade Probiotics Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Bifidobacterium
1.2.3 Lactobacillus
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Pharmaceutical Ggrade Probiotics Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Nutraceuticals
1.3.3 Dietary Supplements
1.3.4 Others
1.4 Global Pharmaceutical Ggrade Probiotics Market Size & Forecast
1.4.1 Global Pharmaceutical Ggrade Probiotics Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Pharmaceutical Ggrade Probiotics Sales in Volume (2017-2028)
1.4.3 Global Pharmaceutical Ggrade Probiotics Price (2017-2028)
1.5 Global Pharmaceutical Ggrade Probiotics Production Capacity Analysis
1.5.1 Global Pharmaceutical Ggrade Probiotics Total Production Capacity (2017-2028)
1.5.2 Global Pharmaceutical Ggrade Probiotics Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Pharmaceutical Ggrade Probiotics Market Drivers
1.6.2 Pharmaceutical Ggrade Probiotics Market Restraints
1.6.3 Pharmaceutical Ggrade Probiotics Trends Analysis
2 Manufacturers Profiles
2.1 DuPont (Danisco)
2.1.1 DuPont (Danisco) Details
2.1.2 DuPont (Danisco) Major Business
2.1.3 DuPont (Danisco) Pharmaceutical Ggrade Probiotics Product and Services
2.1.4 DuPont (Danisco) Pharmaceutical Ggrade Probiotics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Chr. Hansen
2.2.1 Chr. Hansen Details
2.2.2 Chr. Hansen Major Business
2.2.3 Chr. Hansen Pharmaceutical Ggrade Probiotics Product and Services
2.2.4 Chr. Hansen Pharmaceutical Ggrade Probiotics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Lallemand
2.3.1 Lallemand Details
2.3.2 Lallemand Major Business
2.3.3 Lallemand Pharmaceutical Ggrade Probiotics Product and Services
2.3.4 Lallemand Pharmaceutical Ggrade Probiotics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 China-Biotics
2.4.1 China-Biotics Details
2.4.2 China-Biotics Major Business
2.4.3 China-Biotics Pharmaceutical Ggrade Probiotics Product and Services
2.4.4 China-Biotics Pharmaceutical Ggrade Probiotics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Nestle
2.5.1 Nestle Details
2.5.2 Nestle Major Business
2.5.3 Nestle Pharmaceutical Ggrade Probiotics Product and Services
2.5.4 Nestle Pharmaceutical Ggrade Probiotics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Danone
2.6.1 Danone Details
2.6.2 Danone Major Business
2.6.3 Danone Pharmaceutical Ggrade Probiotics Product and Services
2.6.4 Danone Pharmaceutical Ggrade Probiotics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Probi
2.7.1 Probi Details
2.7.2 Probi Major Business
2.7.3 Probi Pharmaceutical Ggrade Probiotics Product and Services
2.7.4 Probi Pharmaceutical Ggrade Probiotics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 BioGaia
2.8.1 BioGaia Details
2.8.2 BioGaia Major Business
2.8.3 BioGaia Pharmaceutical Ggrade Probiotics Product and Services
2.8.4 BioGaia Pharmaceutical Ggrade Probiotics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Yakult
2.9.1 Yakult Details
2.9.2 Yakult Major Business
2.9.3 Yakult Pharmaceutical Ggrade Probiotics Product and Services
2.9.4 Yakult Pharmaceutical Ggrade Probiotics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Novozymes
2.10.1 Novozymes Details
2.10.2 Novozymes Major Business
2.10.3 Novozymes Pharmaceutical Ggrade Probiotics Product and Services
2.10.4 Novozymes Pharmaceutical Ggrade Probiotics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Valio
2.11.1 Valio Details
2.11.2 Valio Major Business
2.11.3 Valio Pharmaceutical Ggrade Probiotics Product and Services
2.11.4 Valio Pharmaceutical Ggrade Probiotics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Glory Biotech
2.12.1 Glory Biotech Details
2.12.2 Glory Biotech Major Business
2.12.3 Glory Biotech Pharmaceutical Ggrade Probiotics Product and Services
2.12.4 Glory Biotech Pharmaceutical Ggrade Probiotics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Greentech
2.13.1 Greentech Details
2.13.2 Greentech Major Business
2.13.3 Greentech Pharmaceutical Ggrade Probiotics Product and Services
2.13.4 Greentech Pharmaceutical Ggrade Probiotics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Bioriginal
2.14.1 Bioriginal Details
2.14.2 Bioriginal Major Business
2.14.3 Bioriginal Pharmaceutical Ggrade Probiotics Product and Services
2.14.4 Bioriginal Pharmaceutical Ggrade Probiotics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Biosearch Life
2.15.1 Biosearch Life Details
2.15.2 Biosearch Life Major Business
2.15.3 Biosearch Life Pharmaceutical Ggrade Probiotics Product and Services
2.15.4 Biosearch Life Pharmaceutical Ggrade Probiotics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Pharmaceutical Ggrade Probiotics Breakdown Data by Manufacturer
3.1 Global Pharmaceutical Ggrade Probiotics Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Pharmaceutical Ggrade Probiotics Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Pharmaceutical Ggrade Probiotics
3.4 Market Concentration Rate
3.4.1 Top 3 Pharmaceutical Ggrade Probiotics Manufacturer Market Share in 2021
3.4.2 Top 6 Pharmaceutical Ggrade Probiotics Manufacturer Market Share in 2021
3.5 Global Pharmaceutical Ggrade Probiotics Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Pharmaceutical Ggrade Probiotics Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Pharmaceutical Ggrade Probiotics Market Size by Region
4.1.1 Global Pharmaceutical Ggrade Probiotics Sales in Volume by Region (2017-2028)
4.1.2 Global Pharmaceutical Ggrade Probiotics Revenue by Region (2017-2028)
4.2 North America Pharmaceutical Ggrade Probiotics Revenue (2017-2028)
4.3 Europe Pharmaceutical Ggrade Probiotics Revenue (2017-2028)
4.4 Asia-Pacific Pharmaceutical Ggrade Probiotics Revenue (2017-2028)
4.5 South America Pharmaceutical Ggrade Probiotics Revenue (2017-2028)
4.6 Middle East and Africa Pharmaceutical Ggrade Probiotics Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Pharmaceutical Ggrade Probiotics Sales in Volume by Type (2017-2028)
5.2 Global Pharmaceutical Ggrade Probiotics Revenue by Type (2017-2028)
5.3 Global Pharmaceutical Ggrade Probiotics Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Pharmaceutical Ggrade Probiotics Sales in Volume by Application (2017-2028)
6.2 Global Pharmaceutical Ggrade Probiotics Revenue by Application (2017-2028)
6.3 Global Pharmaceutical Ggrade Probiotics Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Pharmaceutical Ggrade Probiotics Sales by Type (2017-2028)
7.2 North America Pharmaceutical Ggrade Probiotics Sales by Application (2017-2028)
7.3 North America Pharmaceutical Ggrade Probiotics Market Size by Country
7.3.1 North America Pharmaceutical Ggrade Probiotics Sales in Volume by Country (2017-2028)
7.3.2 North America Pharmaceutical Ggrade Probiotics Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Pharmaceutical Ggrade Probiotics Sales by Type (2017-2028)
8.2 Europe Pharmaceutical Ggrade Probiotics Sales by Application (2017-2028)
8.3 Europe Pharmaceutical Ggrade Probiotics Market Size by Country
8.3.1 Europe Pharmaceutical Ggrade Probiotics Sales in Volume by Country (2017-2028)
8.3.2 Europe Pharmaceutical Ggrade Probiotics Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Pharmaceutical Ggrade Probiotics Sales by Type (2017-2028)
9.2 Asia-Pacific Pharmaceutical Ggrade Probiotics Sales by Application (2017-2028)
9.3 Asia-Pacific Pharmaceutical Ggrade Probiotics Market Size by Region
9.3.1 Asia-Pacific Pharmaceutical Ggrade Probiotics Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Pharmaceutical Ggrade Probiotics Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Pharmaceutical Ggrade Probiotics Sales by Type (2017-2028)
10.2 South America Pharmaceutical Ggrade Probiotics Sales by Application (2017-2028)
10.3 South America Pharmaceutical Ggrade Probiotics Market Size by Country
10.3.1 South America Pharmaceutical Ggrade Probiotics Sales in Volume by Country (2017-2028)
10.3.2 South America Pharmaceutical Ggrade Probiotics Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Pharmaceutical Ggrade Probiotics Sales by Type (2017-2028)
11.2 Middle East & Africa Pharmaceutical Ggrade Probiotics Sales by Application (2017-2028)
11.3 Middle East & Africa Pharmaceutical Ggrade Probiotics Market Size by Country
11.3.1 Middle East & Africa Pharmaceutical Ggrade Probiotics Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Pharmaceutical Ggrade Probiotics Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Pharmaceutical Ggrade Probiotics and Key Manufacturers
12.2 Manufacturing Costs Percentage of Pharmaceutical Ggrade Probiotics
12.3 Pharmaceutical Ggrade Probiotics Production Process
12.4 Pharmaceutical Ggrade Probiotics Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Pharmaceutical Ggrade Probiotics Typical Distributors
13.3 Pharmaceutical Ggrade Probiotics Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Pharmaceutical Ggrade Probiotics Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Pharmaceutical Ggrade Probiotics Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. DuPont (Danisco) Basic Information, Manufacturing Base and Competitors
Table 4. DuPont (Danisco) Major Business
Table 5. DuPont (Danisco) Pharmaceutical Ggrade Probiotics Product and Services
Table 6. DuPont (Danisco) Pharmaceutical Ggrade Probiotics Sales (MT), Price (US$/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Chr. Hansen Basic Information, Manufacturing Base and Competitors
Table 8. Chr. Hansen Major Business
Table 9. Chr. Hansen Pharmaceutical Ggrade Probiotics Product and Services
Table 10. Chr. Hansen Pharmaceutical Ggrade Probiotics Sales (MT), Price (US$/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Lallemand Basic Information, Manufacturing Base and Competitors
Table 12. Lallemand Major Business
Table 13. Lallemand Pharmaceutical Ggrade Probiotics Product and Services
Table 14. Lallemand Pharmaceutical Ggrade Probiotics Sales (MT), Price (US$/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. China-Biotics Basic Information, Manufacturing Base and Competitors
Table 16. China-Biotics Major Business
Table 17. China-Biotics Pharmaceutical Ggrade Probiotics Product and Services
Table 18. China-Biotics Pharmaceutical Ggrade Probiotics Sales (MT), Price (US$/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Nestle Basic Information, Manufacturing Base and Competitors
Table 20. Nestle Major Business
Table 21. Nestle Pharmaceutical Ggrade Probiotics Product and Services
Table 22. Nestle Pharmaceutical Ggrade Probiotics Sales (MT), Price (US$/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Danone Basic Information, Manufacturing Base and Competitors
Table 24. Danone Major Business
Table 25. Danone Pharmaceutical Ggrade Probiotics Product and Services
Table 26. Danone Pharmaceutical Ggrade Probiotics Sales (MT), Price (US$/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Probi Basic Information, Manufacturing Base and Competitors
Table 28. Probi Major Business
Table 29. Probi Pharmaceutical Ggrade Probiotics Product and Services
Table 30. Probi Pharmaceutical Ggrade Probiotics Sales (MT), Price (US$/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. BioGaia Basic Information, Manufacturing Base and Competitors
Table 32. BioGaia Major Business
Table 33. BioGaia Pharmaceutical Ggrade Probiotics Product and Services
Table 34. BioGaia Pharmaceutical Ggrade Probiotics Sales (MT), Price (US$/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Yakult Basic Information, Manufacturing Base and Competitors
Table 36. Yakult Major Business
Table 37. Yakult Pharmaceutical Ggrade Probiotics Product and Services
Table 38. Yakult Pharmaceutical Ggrade Probiotics Sales (MT), Price (US$/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Novozymes Basic Information, Manufacturing Base and Competitors
Table 40. Novozymes Major Business
Table 41. Novozymes Pharmaceutical Ggrade Probiotics Product and Services
Table 42. Novozymes Pharmaceutical Ggrade Probiotics Sales (MT), Price (US$/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Valio Basic Information, Manufacturing Base and Competitors
Table 44. Valio Major Business
Table 45. Valio Pharmaceutical Ggrade Probiotics Product and Services
Table 46. Valio Pharmaceutical Ggrade Probiotics Sales (MT), Price (US$/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Glory Biotech Basic Information, Manufacturing Base and Competitors
Table 48. Glory Biotech Major Business
Table 49. Glory Biotech Pharmaceutical Ggrade Probiotics Product and Services
Table 50. Glory Biotech Pharmaceutical Ggrade Probiotics Sales (MT), Price (US$/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Greentech Basic Information, Manufacturing Base and Competitors
Table 52. Greentech Major Business
Table 53. Greentech Pharmaceutical Ggrade Probiotics Product and Services
Table 54. Greentech Pharmaceutical Ggrade Probiotics Sales (MT), Price (US$/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Bioriginal Basic Information, Manufacturing Base and Competitors
Table 56. Bioriginal Major Business
Table 57. Bioriginal Pharmaceutical Ggrade Probiotics Product and Services
Table 58. Bioriginal Pharmaceutical Ggrade Probiotics Sales (MT), Price (US$/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Biosearch Life Basic Information, Manufacturing Base and Competitors
Table 60. Biosearch Life Major Business
Table 61. Biosearch Life Pharmaceutical Ggrade Probiotics Product and Services
Table 62. Biosearch Life Pharmaceutical Ggrade Probiotics Sales (MT), Price (US$/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Global Pharmaceutical Ggrade Probiotics Sales by Manufacturer (2019, 2020, 2021, and 2022) & (MT)
Table 64. Global Pharmaceutical Ggrade Probiotics Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 65. Market Position of Manufacturers in Pharmaceutical Ggrade Probiotics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 66. Global Pharmaceutical Ggrade Probiotics Production Capacity by Company, (MT): 2020 VS 2021
Table 67. Head Office and Pharmaceutical Ggrade Probiotics Production Site of Key Manufacturer
Table 68. Pharmaceutical Ggrade Probiotics New Entrant and Capacity Expansion Plans
Table 69. Pharmaceutical Ggrade Probiotics Mergers & Acquisitions in the Past Five Years
Table 70. Global Pharmaceutical Ggrade Probiotics Sales by Region (2017-2022) & (MT)
Table 71. Global Pharmaceutical Ggrade Probiotics Sales by Region (2023-2028) & (MT)
Table 72. Global Pharmaceutical Ggrade Probiotics Revenue by Region (2017-2022) & (USD Million)
Table 73. Global Pharmaceutical Ggrade Probiotics Revenue by Region (2023-2028) & (USD Million)
Table 74. Global Pharmaceutical Ggrade Probiotics Sales by Type (2017-2022) & (MT)
Table 75. Global Pharmaceutical Ggrade Probiotics Sales by Type (2023-2028) & (MT)
Table 76. Global Pharmaceutical Ggrade Probiotics Revenue by Type (2017-2022) & (USD Million)
Table 77. Global Pharmaceutical Ggrade Probiotics Revenue by Type (2023-2028) & (USD Million)
Table 78. Global Pharmaceutical Ggrade Probiotics Price by Type (2017-2022) & (US$/MT)
Table 79. Global Pharmaceutical Ggrade Probiotics Price by Type (2023-2028) & (US$/MT)
Table 80. Global Pharmaceutical Ggrade Probiotics Sales by Application (2017-2022) & (MT)
Table 81. Global Pharmaceutical Ggrade Probiotics Sales by Application (2023-2028) & (MT)
Table 82. Global Pharmaceutical Ggrade Probiotics Revenue by Application (2017-2022) & (USD Million)
Table 83. Global Pharmaceutical Ggrade Probiotics Revenue by Application (2023-2028) & (USD Million)
Table 84. Global Pharmaceutical Ggrade Probiotics Price by Application (2017-2022) & (US$/MT)
Table 85. Global Pharmaceutical Ggrade Probiotics Price by Application (2023-2028) & (US$/MT)
Table 86. North America Pharmaceutical Ggrade Probiotics Sales by Country (2017-2022) & (MT)
Table 87. North America Pharmaceutical Ggrade Probiotics Sales by Country (2023-2028) & (MT)
Table 88. North America Pharmaceutical Ggrade Probiotics Revenue by Country (2017-2022) & (USD Million)
Table 89. North America Pharmaceutical Ggrade Probiotics Revenue by Country (2023-2028) & (USD Million)
Table 90. North America Pharmaceutical Ggrade Probiotics Sales by Type (2017-2022) & (MT)
Table 91. North America Pharmaceutical Ggrade Probiotics Sales by Type (2023-2028) & (MT)
Table 92. North America Pharmaceutical Ggrade Probiotics Sales by Application (2017-2022) & (MT)
Table 93. North America Pharmaceutical Ggrade Probiotics Sales by Application (2023-2028) & (MT)
Table 94. Europe Pharmaceutical Ggrade Probiotics Sales by Country (2017-2022) & (MT)
Table 95. Europe Pharmaceutical Ggrade Probiotics Sales by Country (2023-2028) & (MT)
Table 96. Europe Pharmaceutical Ggrade Probiotics Revenue by Country (2017-2022) & (USD Million)
Table 97. Europe Pharmaceutical Ggrade Probiotics Revenue by Country (2023-2028) & (USD Million)
Table 98. Europe Pharmaceutical Ggrade Probiotics Sales by Type (2017-2022) & (MT)
Table 99. Europe Pharmaceutical Ggrade Probiotics Sales by Type (2023-2028) & (MT)
Table 100. Europe Pharmaceutical Ggrade Probiotics Sales by Application (2017-2022) & (MT)
Table 101. Europe Pharmaceutical Ggrade Probiotics Sales by Application (2023-2028) & (MT)
Table 102. Asia-Pacific Pharmaceutical Ggrade Probiotics Sales by Region (2017-2022) & (MT)
Table 103. Asia-Pacific Pharmaceutical Ggrade Probiotics Sales by Region (2023-2028) & (MT)
Table 104. Asia-Pacific Pharmaceutical Ggrade Probiotics Revenue by Region (2017-2022) & (USD Million)
Table 105. Asia-Pacific Pharmaceutical Ggrade Probiotics Revenue by Region (2023-2028) & (USD Million)
Table 106. Asia-Pacific Pharmaceutical Ggrade Probiotics Sales by Type (2017-2022) & (MT)
Table 107. Asia-Pacific Pharmaceutical Ggrade Probiotics Sales by Type (2023-2028) & (MT)
Table 108. Asia-Pacific Pharmaceutical Ggrade Probiotics Sales by Application (2017-2022) & (MT)
Table 109. Asia-Pacific Pharmaceutical Ggrade Probiotics Sales by Application (2023-2028) & (MT)
Table 110. South America Pharmaceutical Ggrade Probiotics Sales by Country (2017-2022) & (MT)
Table 111. South America Pharmaceutical Ggrade Probiotics Sales by Country (2023-2028) & (MT)
Table 112. South America Pharmaceutical Ggrade Probiotics Revenue by Country (2017-2022) & (USD Million)
Table 113. South America Pharmaceutical Ggrade Probiotics Revenue by Country (2023-2028) & (USD Million)
Table 114. South America Pharmaceutical Ggrade Probiotics Sales by Type (2017-2022) & (MT)
Table 115. South America Pharmaceutical Ggrade Probiotics Sales by Type (2023-2028) & (MT)
Table 116. South America Pharmaceutical Ggrade Probiotics Sales by Application (2017-2022) & (MT)
Table 117. South America Pharmaceutical Ggrade Probiotics Sales by Application (2023-2028) & (MT)
Table 118. Middle East & Africa Pharmaceutical Ggrade Probiotics Sales by Region (2017-2022) & (MT)
Table 119. Middle East & Africa Pharmaceutical Ggrade Probiotics Sales by Region (2023-2028) & (MT)
Table 120. Middle East & Africa Pharmaceutical Ggrade Probiotics Revenue by Region (2017-2022) & (USD Million)
Table 121. Middle East & Africa Pharmaceutical Ggrade Probiotics Revenue by Region (2023-2028) & (USD Million)
Table 122. Middle East & Africa Pharmaceutical Ggrade Probiotics Sales by Type (2017-2022) & (MT)
Table 123. Middle East & Africa Pharmaceutical Ggrade Probiotics Sales by Type (2023-2028) & (MT)
Table 124. Middle East & Africa Pharmaceutical Ggrade Probiotics Sales by Application (2017-2022) & (MT)
Table 125. Middle East & Africa Pharmaceutical Ggrade Probiotics Sales by Application (2023-2028) & (MT)
Table 126. Pharmaceutical Ggrade Probiotics Raw Material
Table 127. Key Manufacturers of Pharmaceutical Ggrade Probiotics Raw Materials
Table 128. Direct Channel Pros & Cons
Table 129. Indirect Channel Pros & Cons
Table 130. Pharmaceutical Ggrade Probiotics Typical Distributors
Table 131. Pharmaceutical Ggrade Probiotics Typical Customers
List of Figures
Figure 1. Pharmaceutical Ggrade Probiotics Picture
Figure 2. Global Pharmaceutical Ggrade Probiotics Revenue Market Share by Type in 2021
Figure 3. Bifidobacterium
Figure 4. Lactobacillus
Figure 5. Others
Figure 6. Global Pharmaceutical Ggrade Probiotics Revenue Market Share by Application in 2021
Figure 7. Nutraceuticals
Figure 8. Dietary Supplements
Figure 9. Others
Figure 10. Global Pharmaceutical Ggrade Probiotics Revenue, (USD Million) & (MT): 2017 & 2021 & 2028
Figure 11. Global Pharmaceutical Ggrade Probiotics Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Pharmaceutical Ggrade Probiotics Sales (2017-2028) & (MT)
Figure 13. Global Pharmaceutical Ggrade Probiotics Price (2017-2028) & (US$/MT)
Figure 14. Global Pharmaceutical Ggrade Probiotics Production Capacity (2017-2028) & (MT)
Figure 15. Global Pharmaceutical Ggrade Probiotics Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. Pharmaceutical Ggrade Probiotics Market Drivers
Figure 17. Pharmaceutical Ggrade Probiotics Market Restraints
Figure 18. Pharmaceutical Ggrade Probiotics Market Trends
Figure 19. Global Pharmaceutical Ggrade Probiotics Sales Market Share by Manufacturer in 2021
Figure 20. Global Pharmaceutical Ggrade Probiotics Revenue Market Share by Manufacturer in 2021
Figure 21. Pharmaceutical Ggrade Probiotics Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 Pharmaceutical Ggrade Probiotics Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 Pharmaceutical Ggrade Probiotics Manufacturer (Revenue) Market Share in 2021
Figure 24. Global Pharmaceutical Ggrade Probiotics Sales Market Share by Region (2017-2028)
Figure 25. Global Pharmaceutical Ggrade Probiotics Revenue Market Share by Region (2017-2028)
Figure 26. North America Pharmaceutical Ggrade Probiotics Revenue (2017-2028) & (USD Million)
Figure 27. Europe Pharmaceutical Ggrade Probiotics Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific Pharmaceutical Ggrade Probiotics Revenue (2017-2028) & (USD Million)
Figure 29. South America Pharmaceutical Ggrade Probiotics Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa Pharmaceutical Ggrade Probiotics Revenue (2017-2028) & (USD Million)
Figure 31. Global Pharmaceutical Ggrade Probiotics Sales Market Share by Type (2017-2028)
Figure 32. Global Pharmaceutical Ggrade Probiotics Revenue Market Share by Type (2017-2028)
Figure 33. Global Pharmaceutical Ggrade Probiotics Price by Type (2017-2028) & (US$/MT)
Figure 34. Global Pharmaceutical Ggrade Probiotics Sales Market Share by Application (2017-2028)
Figure 35. Global Pharmaceutical Ggrade Probiotics Revenue Market Share by Application (2017-2028)
Figure 36. Global Pharmaceutical Ggrade Probiotics Price by Application (2017-2028) & (US$/MT)
Figure 37. North America Pharmaceutical Ggrade Probiotics Sales Market Share by Type (2017-2028)
Figure 38. North America Pharmaceutical Ggrade Probiotics Sales Market Share by Application (2017-2028)
Figure 39. North America Pharmaceutical Ggrade Probiotics Sales Market Share by Country (2017-2028)
Figure 40. North America Pharmaceutical Ggrade Probiotics Revenue Market Share by Country (2017-2028)
Figure 41. United States Pharmaceutical Ggrade Probiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada Pharmaceutical Ggrade Probiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico Pharmaceutical Ggrade Probiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe Pharmaceutical Ggrade Probiotics Sales Market Share by Type (2017-2028)
Figure 45. Europe Pharmaceutical Ggrade Probiotics Sales Market Share by Application (2017-2028)
Figure 46. Europe Pharmaceutical Ggrade Probiotics Sales Market Share by Country (2017-2028)
Figure 47. Europe Pharmaceutical Ggrade Probiotics Revenue Market Share by Country (2017-2028)
Figure 48. Germany Pharmaceutical Ggrade Probiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Pharmaceutical Ggrade Probiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Pharmaceutical Ggrade Probiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Pharmaceutical Ggrade Probiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Pharmaceutical Ggrade Probiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Pharmaceutical Ggrade Probiotics Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Pharmaceutical Ggrade Probiotics Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Pharmaceutical Ggrade Probiotics Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Pharmaceutical Ggrade Probiotics Revenue Market Share by Region (2017-2028)
Figure 57. China Pharmaceutical Ggrade Probiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Pharmaceutical Ggrade Probiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea Pharmaceutical Ggrade Probiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Pharmaceutical Ggrade Probiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Pharmaceutical Ggrade Probiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Pharmaceutical Ggrade Probiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Pharmaceutical Ggrade Probiotics Sales Market Share by Type (2017-2028)
Figure 64. South America Pharmaceutical Ggrade Probiotics Sales Market Share by Application (2017-2028)
Figure 65. South America Pharmaceutical Ggrade Probiotics Sales Market Share by Country (2017-2028)
Figure 66. South America Pharmaceutical Ggrade Probiotics Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Pharmaceutical Ggrade Probiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Pharmaceutical Ggrade Probiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa Pharmaceutical Ggrade Probiotics Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa Pharmaceutical Ggrade Probiotics Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa Pharmaceutical Ggrade Probiotics Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa Pharmaceutical Ggrade Probiotics Revenue Market Share by Region (2017-2028)
Figure 73. Turkey Pharmaceutical Ggrade Probiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt Pharmaceutical Ggrade Probiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Pharmaceutical Ggrade Probiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa Pharmaceutical Ggrade Probiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of Pharmaceutical Ggrade Probiotics in 2021
Figure 78. Manufacturing Process Analysis of Pharmaceutical Ggrade Probiotics
Figure 79. Pharmaceutical Ggrade Probiotics Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • プロバイオティクスサプリメントのグローバル市場展望 2023年-2029年：乳酸菌、ビフィズス菌、その他
  • 世界のプロバイオティクスベース栄養補助食品市場2022年：市場規模予測（～2028年）
  • 世界のビフィズス菌プロバイオティクス市場2022年：市場規模予測（～2028年）
  • 世界の食品用プロバイオティクス市場2022年：市場規模予測（～2028年）
  • 世界のプロバイオティクスサプリメント市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19535 )"世界の医薬品用プロバイオティクス市場2022年：市場規模予測（～2028年）" (英文：Global Pharmaceutical Ggrade Probiotics Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。